title: Does accepting pharmacokinetic recommendations impact hospitalization? A cost-benefit analysis.
abstract: In a prospective, randomized study, 110 adults receiving aminoglycosides were randomized to follow-up by a clinical pharmacokinetic service (CPS). Of the 110 patients, 35 accepted pharmacokinetic recommendations less than 100% of the time. The two groups were similar in age, sex, height, APACHE II score, and initial creatinine clearance. A cost-to-charge ratio was used to derive direct costs of hospitalization and calculate cost-benefit. Patients whose physicians accepted pharmacokinetic recommendations 100% of the time had shorter hospitalizations (322.67 +/- 270.28 h; CPS less than 100%, 699.54 +/- 806.35; p = 0.001) and febrile periods (50.05 +/- 79.38 h; CPS less than 100%, 120.00 +/- 153.23; p = 0.002). Acceptance of CPS recommendations led to adequate peak levels. Acceptance of CPS recommendations led to lower direct costs ($7,102.56 +/- 9,898.19; CPS less than 100%, $19,629.94 +/- 28,051.89; p less than 0.001). Calculated direct cost of the service was $85/patient.
authors: Clinical Pharmacokinetic Service, AMI Saint Joseph Hospital, Omaha, Nebraska.
authors: C J
authors: CJ
authors: Destache
authors: S K
authors: SK
authors: Meyer
authors: K M
authors: KM
authors: Rowley
mesh_terms: D000617:Aminoglycosides / Q000097:blood* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005260:Female; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D007902:Length of Stay; D008297:Male; D008991:Monitoring, Physiologic / Q000191:economics*; D011446:Prospective Studies
chemical_list: D000617:Aminoglycosides